ロード中...
Vaccine nanoparticles for protection against HIV infection
The development of a successful vaccine against HIV is a major global challenge. Antiretroviral therapy is the standard treatment against HIV-1 infection. However, only 46% of the eligible people received the therapy in 2015. Furthermore, suboptimal adherence poses additional obstacles. Therefore, t...
保存先:
| 出版年: | Nanomedicine (Lond) |
|---|---|
| 主要な著者: | , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Future Medicine Ltd
2017
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5331416/ https://ncbi.nlm.nih.gov/pubmed/28244816 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2217/nnm-2016-0381 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|